Bring AI-assisted digital pathology to your clinical and research workflows.
Translyx represents Aiforia as an authorised partner in New Zealand — helping pathology groups, laboratories, and research teams adopt AI-assisted digital pathology with governance, human oversight, and clinical confidence.
From glass slides to governed, quantitative insight
Digital pathology moves the slide into software. AI-assisted analysis adds consistent, reviewable measurement — supporting specialists rather than replacing clinical judgement.
Quantitative image analysis
AI-assisted analysis helps quantify and locate features across whole-slide images, supporting consistent, reviewable assessment.
Scale across cohorts
Analyse large slide cohorts with reproducible methodology — useful for high-volume reporting and research studies.
Workflow efficiency
Support specialists with structured, repeatable outputs that fit into existing reporting and research processes.
Adoption support across the pathology ecosystem
Pathology groups
AI-assisted reporting support for clinical pathology teams, with the pathologist firmly in the decision.
Laboratories
Digital pathology adoption support for laboratories modernising image analysis and reporting workflows.
Research & preclinical
Reproducible quantitative analysis for translational research, biomarker exploration, and preclinical programmes.
Authorised partner solution
Powered by Aiforia — represented by Translyx in New Zealand
Aiforia is an authorised partner solution, not a Translyx-owned product. As the local business partner, Translyx supports evaluation, onboarding, and responsible adoption — with visible limitations and no implied regulatory endorsement.
Modernise pathology with governed digital pathology AI.
Talk to Translyx about adopting AI-assisted digital pathology across your clinical, preclinical, and research workflows.